An analysis of polygenic risk scores for non-alcoholic fatty liver disease

Similar Items

• The role of single nucleotide polymorphism TLR4 in the development of the non-alcoholic fatty liver disease in children
  by: Yu.M. Stepanov, et al.
  Published: (2020-05-01)
• Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment
  by: Hyunwoo Oh, et al.
  Published: (2016-09-01)
• Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
  by: Francesca Cainelli, et al.
  Published: (2020-02-01)
• Association of adiponectin rs17300539 gene polymorphism with a non-alcoholic fatty liver disease in an Iranian population
  by: Fahimeh Rezaei, et al.
  Published: (2018-10-01)
• Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease(♦)(♦)This work was supported by grants from the Fondo Nacional de Ciencia y Tecnología de Chile (FONDECYT) #1110455 to M.A., #1100971 to M.A-L. and #1100020 to F.N.
  by: Alberto Espino, et al.
  Published: (2011-10-01)